[ Mon, Apr 12th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Fri, Apr 09th 2021 ]: WOPRAI
[ Thu, Apr 08th 2021 ]: WOPRAI
Anita Dushyanth Initiated (BTAI) at Strong Buy and Held Target at $75 on, Apr 9th, 2021
- 🞛 This publication is a summary or evaluation of another publication
Anita Dushyanth of Berenberg, Initiated "BioXcel Therapeutics, Inc." (BTAI) at Strong Buy and Held Target at $75 on, Apr 9th, 2021.
Anita has made no other calls on BTAI in the last 4 months.
There are 4 other peers that have a rating on BTAI. Out of the 4 peers that are also analyzing BTAI, 0 agree with Anita's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Anita
- Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $175 on, Thursday, April 1st, 2021
- Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Decreased Target to $127 on, Thursday, April 1st, 2021
- Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $95 on, Thursday, April 1st, 2021
- Colin Bristow of "UBS" Initiated at Strong Buy and Held Target at $99 on, Monday, February 1st, 2021